Sanofi considers work cuts as CEO Paul Hudson tries to decrease costs Kumar Jeetendra | June 26, 2020 Sanofi is thinking about eliminating several positions and will talk about expected strides with staff delegates over the coming days, five sources said on Thursday, the most recent move by the French drugmaker’s CEO Paul Hudson to reduce expenses. The executives will meet staff agents on Friday and Monday one week from now to plot …
Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI) Kumar Jeetendra | August 20, 2020 India, Mumbai, August 20th , 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due …
